Physician profile
Robert Pearce
NPI 1598185506
$4,376.61
in general payments reported to CMS, 2019-2025
19 companies · $396 in 2025
The $396 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,575 · 2020: $369 · 2021: $363 · 2022: $236 · 2023: $1,198 · 2024: $241 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $943 · Travel and Lodging: $892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $942.72 |
| Travel and Lodging | $891.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,214.56 | 2019-2024 | Mitraclip |
| E.R. Squibb & Sons, L.L.C. | $348.53 | 2019-2023 | Camzyos, Eliquis |
| Boston Scientific Corporation | $248.48 | 2020-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $241.97 | 2021-2023 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $217.79 | 2019-2020 | |
| Edwards Lifesciences Corporation | $147.33 | 2025 | Evoque |
| Novartis Pharmaceuticals Corporation | $118.96 | 2024-2025 | |
| Pfizer INC. | $113.32 | 2019-2025 | |
| Vifor Pharma, INC. | $111.33 | 2021 | |
| Medtronic Vascular, INC. | $108.96 | 2019 | |
| Heartflow, INC. | $103.32 | 2024-2025 | |
| Inari Medical, INC. | $89.14 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.79 | 2019 | |
| Kestra Medical Technology Services, INC. | $75.64 | 2025 | Assure Wcd |
| Lantheus Medical Imaging, INC. | $60.57 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $24.51 | 2025 | |
| Cardiovascular Systems INC. | $23.00 | 2021 | |
| Chiesi USA, INC. | $21.39 | 2020 | |
| Amgen INC. | $19.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Pearce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.